Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation

Fig. 6

Molecular docking model of the biochanin A with the 3 core proteins. A NFATc1-BCA-3D (protein surface); (B) NFATc1-BCA-3D (cartoon model); (C) NFATc1-BCA-2D; (D) ERK-BCA-3D (protein surface); (E) ERK-BCA-3D (cartoon model); (F) ERK-BCA-2D; (G) JNK-BCA-3D (protein surface); (H) JNK-BCA-3D (cartoon model); (I) JNK-BCA-2D; (J) c-FOS-BCA-3D (protein surface) ; K c-FOS-BCA-3D (cartoon model); L c-FOS-BCA-2D

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us